Anavex Invest Advisor

Anavex Life Sciences Announces Participation in H.C. Wainwright Neuro Conference Jun 21, 2024

Anavex Life Sciences Expands Leadership Amidst Clinical Advancements May 22, 2024

Anavex Life Sciences Commences Phase 2 Trial of ANAVEX®3-71 for Schizophrenia Mar 18, 2024

Anavex Life Sciences Presents at the 44th Annual TD Cowen Health Care Conference Feb 26, 2024

Five Stocks Ascend to Zacks Rank #1 on January 26: IKT, EGO, MDB, PD, and AVXL Jan 27, 2024

Anavex Life Sciences Secures U.S. Patent for Blarcamesine in the Treatment of Insomnia and Anxiety Nov 23, 2023